Increased HDAC in association with decreased plasma cortisol in older adults with chronic fatigue syndrome

Brain, Behavior, and Immunity

Volumn 25, Issue 8, 2011, Pages 1544-1547

  Jason, Leonard ^a   Sorenson, Matthew ^a   Sebally, Kebba ^b   Alkazemi, Dalal ^b   Lerch, Athena ^a   Porter, Nicole ^a   Kubow, Stan ^b  

^a DEPAUL UNIVERSITY   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Chronic fatigue; Cortisol; Dehydroepiandrosterone; Histone deacetylase; Oxidative stress

Indexed keywords

CYSTEINE; GLUCOCORTICOID RECEPTOR; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE H3; HYDROCORTISONE; NERVE GROWTH FACTOR; NUCLEAR GLUCOCORTICOID RECEPTOR SUBFAMILY 3 GROUP C MEMBER 1; PRASTERONE; SIRTUIN 1; UNCLASSIFIED DRUG;

AGED; ARTICLE; CHROMATIN; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; NITROSYLATION; OXIDATIVE STRESS; PILOT STUDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; DEHYDROEPIANDROSTERONE; FATIGUE SYNDROME, CHRONIC; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTONE DEACETYLASES; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NERVE GROWTH FACTORS; OXIDATIVE STRESS; PITUITARY-ADRENAL SYSTEM; RNA;

EID: 80053900289     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.04.007     Document Type: Article

References (32)

1. Adcock I.M., Ito K., Barnes P.J. Glucocorticoids: effects on gene transcription. Proc. Am. Thorac. Soc. 2004, 1:247-254.
2. Adcock I.M., Cosio B., Tsaprouni L., Barnes P.J., Ito K. Redox regulation of histone deacetylases and glucocorticoid-mediated inhibition of the inflammatory response. Antioxid. Redox Signal. 2005, 7:144-152.
3. Adenuga D., Rahman I. Oxidative stress, histone deacetylase and corticosteroid resistance in severe asthma and COPD. Curr. Res. Med. Rev. 2007, 3:57-68.
4. Barnes P.J. How corticosteroids control inflammation: quintiles prize lecture 2005. Br. J. Pharmacol. 2006, 148:245-254.
5. Belden W.J., Dunlap J.C. SIRT1 is a circadian deacetylase for core clock components. Cell 2008, 134:212-214.
6. Benzie I.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal. Biochem. 1996, 239:70-76.
7. Cleare A.J. The neuroendocrinology of chronic fatigue syndrome. Endocr. Rev. 2003, 24:236-252.
8. Dangond F., Hafler D.A., Tong J.K., Randall J., Kojima R., Utku N., Gullans S.R. Differential display cloning of a novel human histone deacetylase (HDAC3) cDNA from PHA-activated immune cells. Biochem. Biophys. Res. Commun. 1998, 242:648-652.
9. Dinan T.G., Majeed T., Lavelle E., Scott L.V., Berti C., Behan P. Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychoneuroendocrinology 1997, 22:261-267.
10. Epel E.S., Blackburn E.H., Lin J., Dhabhar F.S., Adler N.E., Morrow J.D., Cawthon R.M. Accelerated telomere shortening in response to life stress. Proc. Natl. Acad. Sci. USA 2004, 101:17312-17315.
11. Frye R.F., Kroboth P.D., Kroboth F.J., Stone R.A., Folan M., Salek F.S., Pollock B.G., Linares A.M., Hakala C. Sex differences in the pharmacokinetics of dehydroepiandrosterone (DHEA) after single- and multiple-dose administration in healthy older adults. J. Clin. Pharmacol. 2000, 40:596-605.
12. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med. 1994, 121:953-959.
13. Gaab J., Huster D., Peisen R., Engert V., Heitz V., Schad T., Schurmeyer T.H., Ehlert U. Hypothalamic-pituitary-adrenal axis reactivity in chronic fatigue syndrome and health under psychological, physiological, and pharmacological stimulation. Psychosom. Med. 2002, 64:951-962.
14. Ito K., Yamamura S., Essilfie-Quaye S., Cosio B., Ito M., Barnes P.J., Adcock I.M. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J. Exp. Med. 2006, 203:7-13.
15. Jason L.A., Sorenson M., Porter N., Brown M., Lerch A., Van der Eb C., Mikovits J. Possible genetic dysregulation in pediatric CFS. Psychology 2010, 1:247-251.
16. Johnson S.K., DeLuca J. Chronic fatigue syndrome and the brain. Fatigue as a Window to the Brain 2005, 137-156. MIT Press, Cambridge, MA. J. DeLuca (Ed.).
17. Kavelaars A., Kuis W., Knook L., Sinnema G., Heijnen C.J. Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 2000, 85:692-696.
18. Matsuura E., Ohta A., Suematsu R., Inoue H., Koarada S., Tada Y., Sherriff-Tadano R., Kuroki T., Ikeda D., Nagasawa K. Functional disturbance of the stress-adaptation system in patients with scleroderma. Mod. Rheumatol. 2011, [Epub ahead of print].
19. Nater U.M., Youngblood L.S., Jones J.F., Unger E.R., Miller A.H., Reeves W.C., Heim C. Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom. Med. 2008, 70:298-305.
20. Nakamura H., Nakamura K., Yodoi J. Redox regulation of cellular activation. Annu. Rev. Immunol. 1997, 15:351-369.
21. Nissen R.M., Yamamoto K.R. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes. Dev. 2000, 15:2314-2329.
22. Okamoto K., Tanaka H., Ogawa H., Makino Y., Eguchi H., Hayashi S., Yoshikawa N., Poellinger L., Umesono K., Makino I. Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J. Biol. Chem. 1999, 274:10363-10371.
23. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung disease. J. Biochem. Mol. Biol. 2003, 36:95-109.
24. Rajeevan M.S., Smith A.K., Dimulescu I., Unger E.R., Vernon S.D., Heim C. Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome. Genes Brain Behav. 2007, 6:167-176.
25. Rautiainen S., Serafini M., Morgenstern R., Prior R.L., Wolk A. The validity and reproducibility of food-frequency questionnaire-based total antioxidant capacity estimates in Swedish women. Am. J. Clin. Nutr. 2008, 87:1247-1253.
26. Rizvi S.I., Jha R., Maurya P.K. Erythrocyte plasma membrane redox system in human aging. Rejuvenation Res. 2006, 9:470-474.
27. Roberts A.D., Papadopoulos A.S., Wessely S., Chalder T., Cleare A.J. Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome. J. Affect. Disord. 2009, 115:280-286.
28. Seidel M.F., Herguijuela M., Forkert R., Otten U. Nerve growth factor in rheumatic diseases. Semin. Arthritis Rheum. 2010, 40:109-126.
29. Skalska A.B., Pietrzycka A., Stepniewski M. Correlation of endothelin 1 plasma levels with plasma antioxidant capacity in elderly patients treated for hypertension. Clin. Biochem. 2009, 42:358-364.
30. Torres-Harding S., Sorenson M., Jason L., Maher K., Fletcher M.A., Reynolds N., Brown M. The associations between basal salivary cortisol and illness symptomatology in chronic fatigue syndrome. J. Appl. Biobehav. Res. 2008, 13:157-180.
31. Yang S.R., Chida A.S., Bauter M.R., Shafiq N., Seweryniak K., Maggirwar S.B., Kilty I., Rahman I. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am. J. Physiol. Lung Cell Mol. Physiol. 2006, 291:L46-L57.
32. Yuan Z., Rezai-Zadeh N., Zhang X., Seto E. Histone deacetylase activity assay. Methods Mol. Biol. 2009, 523:279-293.